Product Images Bortezomib
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Bortezomib NDC 10019-991 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bortezomib Chemical Structure - image 01
Figure 1: Time to Progression Bortezomib for Injection, Melphalan and Prednisone vs Melphalan and Prednisone - image 02
Figure 2: Overall Survival Bortezomib for Injection, Melphalan and Prednisone vs Melphalan and Prednisone - image 03
Figure 3: Time to Progression Bortezomib vs Dexamethasone (Relapsed Multiple Myeloma Study) - image 04
The text provided contains statistical analysis and graphs indicating the proportion of patients remaining with time. The treatment groups Bonwzomib and Dexamethasone are compared, and a p-value from a log-rank test is mentioned. Therefore, the text seems to describe the survival analysis of patients under two treatments.*
Figure 4: Overall Survival Bortezomib vs Dexamethasone (Relapsed Multiple Myeloma Study) - image 05
This is clinical data related to the use of Bortezomib and Dexamethasone. The table shows the number of patients remaining after a certain time point for each treatment. A p-value from a log-rank test is also provided.*
Figure 5: Progression Free Survival VcR-CAP vs R-CHOP (previously Untreated Mantle Cell Lymphoma Study) - image 06
Figure 6: Overall Survival VcR-CAP vs R-CHOP (previously Untreated Mantle Cell Lymphoma Study) - image 07
Bortezomib Representative Container Label 10019-991-01 - image 08
Representative Bortezomib Intravenous Label 10019-991-01 - image 09
Bortezomib for Injection is a medication that can be intravenously injected with 0.9% sodium chloride to achieve a final concentration of 1 mg/mL. Stickers should be placed on the vial and syringe, and the package insert should be followed for full instructions. The given code number is 0540 408-10-3-VH VSN.*
Representative Bortezomib Subcutaneous Label 10019-991-01 - image 10
Bortezomib for Injection is a medication that is prepared by mixing 1.4mL of solution with 0.9% Sodium Chloride in order to achieve a final concentration of 2.5 mg/mL. A sticker must be placed on both the vial and syringe. Additional instructions should be found in the 91008-10-S3-VH VSN Package Insert (Section 2).*
Bortezomib Representative Carton Label 10019-991-01 1 of 2 - image 11
Bortezomib Representative Carton Label 10019-991-01 2 of 2 - image 12
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.